STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

Henrik Lundvall

Head of content

Henrik has extensive experience in senior roles within international media and tech companies, including TT, Expressen, Microsoft, Axel Springer and Lifesum. At Yazen, he is Head of Content, with responsibility for strategy, marketing and in-app content, working closely with product, medical and tech teams.

LinkedIn logo
Portrait imageOrange stylized human head with colorful flowers and vines growing out from the top and back.

Henrik Lundvall has a solid background in leadership roles across international digital media and tech companies. He started his career in local media in Sweden and has since held senior roles at TT, Expressen and Microsoft, where he worked as Operations Lead. Within the Axel Springer group, he was responsible for launching the company’s products across 28 international markets, and he has also been Managing Editor at Lifesum.

At Yazen, Henrik is Head of Content. He’s responsible for everything related to content across the business – from content and communications strategy to marketing, in-app content and business development. In his role, he leads cross-functional teams and works closely with product, doctors and tech teams to make sure the content is evidence-based, engaging and genuinely useful for the people using Yazen.

Articles by

Henrik Lundvall

Weight Loss Injection Treatment – How Does It Work?

Weight loss injections have emerged as an evidence-based medical treatment for obesity and overweight. By mimicking the body's natural hormones, these prescription medications help regulate appetite and support sustainable weight management. In this guide, we explore how injectable weight loss treatments work, who is eligible, and what to expect when combining them with professional medical support.

What happens if you stop taking Mounjaro?

Stopping Mounjaro often brings up a lot of questions. If you’ve been using it to support weight loss or improve your metabolic health, it’s completely natural to wonder what happens next.

Mounjaro is a prescription medicine containing tirzepatide. In the UK, it’s licensed for type 2 diabetes and weight management, alongside lifestyle changes. But what actually happens in your body when you stop treatment? Will the weight come back? And is it possible to keep the results long term?

Side effects of Ozempic and Wegovy: what’s common and what should you look out for?

Interest in medicines containing semaglutide, such as Ozempic and Wegovy, has grown quickly in recent years. With proven effects, it’s natural that questions about safety and side effects follow. How does the treatment affect your body? Is it safe? And what can you do if you feel sick, for example?

Mounjaro side effects: common symptoms and how to manage them

Mounjaro (tirzepatide) is a prescription medicine used to treat adults with type 2 diabetes and, in some cases, to support weight management in people living with obesity, or overweight with at least one weight-related health condition.

What happens if you stop taking Ozempic?

Stopping Ozempic can raise a lot of questions, especially if you’ve been using semaglutide to support weight loss or improve your metabolic health. What actually happens in your body? Will the weight come back?

In this article, we’ll look at what the research shows about what can happen when you stop taking Ozempic or Wegovy, and what can influence the outcome.

Can you use GLP-1 while breastfeeding – what does the research say?

After pregnancy, it’s completely normal to want to focus on your own health again. At the same time, many people hear about GLP-1 medications such as Ozempic, Wegovy and Mounjaro as effective treatments for overweight and obesity. That often leads to questions about why these medicines aren’t recommended while breastfeeding.

The short answer comes down to your baby’s safety, limited research, and the fact that your body has different needs during this stage.

Why you shouldn’t use GLP-1 during pregnancy. How it can affect you and your baby

Pregnancy brings big changes to the body, so it’s completely natural to wonder what’s safe when it comes to medication. Can you use GLP-1 treatments like Ozempic or Wegovy while pregnant? Here, we’ll walk through what the research says, why these medicines aren’t recommended during pregnancy, and what to think about if you’re pregnant or planning to be.

What happens if you stop taking GLP-1?

Stopping GLP-1 treatment, such as Ozempic, Wegovy or Mounjaro, raises a lot of questions for people who’ve used it to lose weight. What actually happens in your body? Will the weight come back? Can you keep the results?

Here, we’ll walk through what the research shows about what tends to happen when treatment comes to an end.

Common side effects of GLP-1 medications and how to manage them

Side effects are common with GLP-1 medications, especially at the start of treatment or when the dose is increased. For most people, they are mild to moderate and tend to affect the stomach and gut. They usually ease as your body adjusts. With the right advice around food, fluids and dosing, discomfort can often be reduced so treatment can continue safely. Here we’ll walk through common side effects and practical tips to help.